• Title/Summary/Keyword: 조현병

Search Result 170, Processing Time 0.031 seconds

Expression Analysis of Schizophrenia Symptoms : Focusing on the Movies and (조현병 증상의 표현 분석 : 영화 <더 보이스>,<블랙 스완>을 중심으로)

  • Choi, Ji-Won
    • The Journal of the Korea Contents Association
    • /
    • v.22 no.9
    • /
    • pp.510-519
    • /
    • 2022
  • This study aims to examine how delusions and hallucinations are expressed as representative symptoms of schizophrenia in the two films and . We look at how the two films show the appearance and overall image of the schizophrenic patient, the emotional expression of the schizophrenic patient, and how family and colleagues express the perceptions of the schizophrenic patient's symptoms. Finally, we will examine the perception of treatment measures for schizophrenia. Comprehensively, through this process, the schizophrenia symptoms expressed in the two films will have some effect on social perception of schizophrenia and the social implications of therapeutic intervention for schizophrenia recovery.

Study on a Diagnosis System using Correlation between Schizophrenia and EEG, MRI data (EEG, MRI와 조현병의 상관관계를 이용한 진단 시스템 연구)

  • Seong, Ji-Hyeon;Kim, Do-Yeon;Kim, Ji-Eun
    • Proceedings of the Korea Information Processing Society Conference
    • /
    • 2020.05a
    • /
    • pp.464-467
    • /
    • 2020
  • 조현병(정신분열증)은 사고, 감정, 지각, 행동 등 인격의 여러 측면에 걸쳐 광범위한 임상적 이상 증상을 일으키는 정신 질환이다. 심각한 정신 질환임에도 불구하고 여전히 과학적 진단 체계가 갖춰져 있지 않아 진단의 많은 부분을 환자의 진술에 의존하고 있으며, 이로 인해 조현병이라는 진단을 받고 치료방법을 찾는데 까지 오랜 시간이 걸린다. 이에 본 연구는 EEG, MRI 데이터와 조현병의 상관관계를 이용한 조현병 진단 시스템을 제안하고자 한다. 본 시스템은 MRI 데이터와 머신러닝 알고리즘을 통한 조현병의 확률적 진단과 함께, EEG 데이터의 시각화 기능을 제공하는 소프트웨어를 개발함으로써 조현병 진단의 과학적 근거를 의사에게 제공하여 정확한 병의 진단을 목표로 한다. 진단 후에는 환자 데이터의 체계적 관리를 통해 머신러닝 알고리즘의 학습 데이터 확보 및 환자의 상태를 지속적으로 관리·관찰 할 수 있도록 하여 의료 소프트웨어로서 조현병의 체계적 진단 및 관리 시스템을 구축한다.

Review of the Neuroscientific Evidences for the People With Schizophrenia (조현병 환자의 신경과학적 근거에 대한 고찰)

  • Shin, Eun-Sik
    • Therapeutic Science for Rehabilitation
    • /
    • v.2 no.1
    • /
    • pp.5-12
    • /
    • 2013
  • The purpose of this review is to address the flow of current neuroscientific researches and to provide for the clinicians with therapeutic evidences for schizophrenia which can help them clinical decision making. Since the very beginning, a lot of scientific studies about schizophrenia have been undertaken. In this review, I describes the evidences focused on development of schizophrenia including neurobiological dysfunction, neurodevelopmental model, Kalirin, and Brain-Derived Neurotrophic Factor(BDNF) and neuroanatomic abnormalities based on neuroimaging studies. In conclusion, schizophrenia influencing on broad impairment of human function such as activities of daily life, occupations, and relationships has been studied underlying causes and treatments, but still remained uncertainty. However, there are plenty of useful evidences available for the clinicians to make a good therapeutic choice.

Social perception of schizophrenic patient as portrayed in Korean films (한국영화에 나타나는 조현병 환자에 대한 사회 인식)

  • Hong, Kyung-Young;Im, Sookbin
    • Journal of Digital Convergence
    • /
    • v.16 no.4
    • /
    • pp.157-166
    • /
    • 2018
  • This study was conducted to identify the social perception of schizophrenic patients through films expressed in schizophrenic patients. We analyzed 48 films and scenarios that have been screened for the last 40 years by content analysis method to perceive interpersonal and emotional perception, perception of families and treatment measures. Patients were violent, dangerous, and burdensome to the family. However, specific experience or internal description has increased, and attitude of family or patients related to treatment has been more actively described since 1996. In conclusion, the perception of patients seen negative, want to avoid, giving burdens and pain to others. Therefore, to improve the social perception of mental disorders, it is necessary to make active use of films that have a high impact on public perception, and try to study the influence of visual media on perception change.

Current Status of Clozapine for Treatment-Resistant Schizophrenia (치료저항성 조현병에서 클로자핀 치료의 현황)

  • Kim, Se Hyun
    • Korean Journal of Schizophrenia Research
    • /
    • v.24 no.1
    • /
    • pp.1-7
    • /
    • 2021
  • Clozapine is the first and most effective atypical antipsychotic drug for treatment-resistant schizophrenia (TRS). After withdrawal of clozapine due to concerns of agranulocytosis, clozapine was reintroduced with a comprehensive safety monitoring system, the clozapine patient monitoring system (CPMS). The reintroduction was a response to the pressure from psychiatrists and patients with TRS and their families. Clozapine is still the best single agent for the treatment of TRS. However, approximately 30% of patients with TRS still show psychotic symptoms. In patients with clozapine-resistant schizophrenia (CRS), augmentation of other antipsychotic agents could be considered after a thorough evaluation of proper clozapine treatment. In this review, the status of clozapine in patients with TRS and CRS will be discussed.

BERT-based Two-Stage Classification Models for Alzheimer's Disease and Schizophrenia Diagnosis (BERT 기반 2단계 분류 모델을 이용한 알츠하이머병 치매와 조현병 진단)

  • Jung, Min-Kyo;Na, Seung-Hoon;Kim, Ko Woon;Shin, Byong-Soo;Chung, Young-Chul
    • Annual Conference on Human and Language Technology
    • /
    • 2021.10a
    • /
    • pp.558-563
    • /
    • 2021
  • 알츠하이머병 치매와 조현병 진단을 위한 2단계 분류 모델을 제안한다. 정상군과 환자군의 발화에 나타난 페어 언어 모델 간의 Perplexity 차이에 기반한 분류와 기존 단일 BERT 모델의 미세조정(fine-tuning)을 이용한 분류의 통합을 시도하였다. Perplexity 기반의 분류 성능이 알츠하이머병, 조현병 모두 우수한 결과를 보임을 확인 하였고, 조현병 분류 모델의 성능이 소폭 증가하였다. 향후 설명 가능한 인공지능 기법을 적용에 따른 성능 향상을 기대할 수 있었다.

  • PDF

Phenomenological Study on the Life of People with Schizophrenia (조현병을 가진 사람의 삶에 대한 현상학적 연구)

  • Park, Mi-Won;Eom, Tae-Wan
    • Journal of Digital Convergence
    • /
    • v.16 no.11
    • /
    • pp.521-533
    • /
    • 2018
  • This study aimed to understand the meaning and essence inherent in the life experiences of people with schizophrenia. We approached with phenomenological method, and the research participants were 10 adults, aged 20 or older, who were diagnosed with schizophrenia. As a result, we found four essential themes. The participants with schizophrenia lived a life with special constraints of being thrown to the reality in which they experienced continuing suffering. Nevertheless, their daily lives were maintained on the basis of their own feelings and needs. In this study, we confirmed that they should be understood and treated in the mental health field with the perspective that they are not 'patients' nor a pathological outcome, but a 'human' with schizophrenia.

Gratitude Experience of Mothers who cares Child with Chronic Schizophrenia (만성조현병환자 어머니의 감사경험)

  • Hong, Ju-Eun
    • Journal of Digital Convergence
    • /
    • v.18 no.1
    • /
    • pp.199-209
    • /
    • 2020
  • This study was done to explore deeply the essence and meaning of gratitude experience of mothers who cares child with schizophrenia. This study was analysed through the use of the phenomenological method of Giorgi. Data was collected through in-depth interviews, observation, and field records with five motheres who cares child with schizophrenia. Data analysis revealed 18 sub-components, 5 components: 'I'm like fallen seed on barren soil without gratitude', 'gratitude coming into bud like sprout,' 'gratitude grown up into a tree through tolerance', 'gratitude bearing fruit of self-sufficiency and desire', and 'gratitude getting much richer with giving. The results from the study contribute to promoting understanding of the gratitude experience of mothers who cares child with schizophrenia and will be helpful for development of positive family nursing intervention.

Supporting Patients With Schizophrenia in the Era of COVID-19 (COVID-19 유행 시기의 조현병 환자 지원)

  • Kim, Sung-Wan
    • Korean Journal of Schizophrenia Research
    • /
    • v.24 no.2
    • /
    • pp.45-51
    • /
    • 2021
  • The coronavirus disease 2019 (COVID-19) pandemic has drastically impacted our society and health care system. People with schizophrenia are more vulnerable to this burden of illness and related societal changes. In addition, they are more susceptible to the transmission of COVID-19 and have a significantly higher mortality rate compared to the general population. In a recent study, vaccinated patients with schizophrenia showed a greatly decreased mortality level similar to that of the general population. However, patients with schizophrenia were less likely to be vaccinated. Mental health professionals should provide them with appropriate information on prevention strategies against COVID-19 and vaccination. Long-lasting social distancing and social disconnection can make people with schizophrenia more vulnerable to loneliness and depression. Furthermore, patients with schizophrenia may face challenges continuing psychiatric treatment due to the COVID-19 pandemic. Social support and suitable mental health services using novel technologies should be developed and provided to patients with schizophrenia.

Pseudo-Resistant Schizophrenia: Non-Adherence to Treatment (치료 위저항성 조현병: 치료 비순응을 중심으로)

  • Kim, Hyerim;Lee, Seung Jae
    • Korean Journal of Schizophrenia Research
    • /
    • v.23 no.2
    • /
    • pp.51-57
    • /
    • 2020
  • Treatment-resistant schizophrenia (TRS) has been defined as the persistence of positive symptoms despite two or more trials of antipsychotic medication of adequate dose and duration. TRS is a serious clinical problem and occurs in approximately 30% of patients with schizophrenia. It is important that patients who do not adequately respond to antipsychotics be reevaluated to exclude or address causes other than non-responsiveness to medication, that is, the possibility of pseudo-resistance. In particular, non-adherence to oral antipsychotic treatment should be monitored to rule out pseudo-resistant cases of TRS. Moreover, patients with TRS who take their medication as required may have subtherapeutic antipsychotic plasma levels, secondary to pharmacokinetic factors. In this paper, we review the concept and exclusion of pseudo-resistance, especially owing to non-adherence or pharmacokinetic factors, and present methods to enhance drug adherence.